Found 24 matching trials
Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms
PHASE2The goal of this clinical trial is to learn whether cabergoline can prevent...
Location
Maimonides Medical Center
PRolaCT - Three Prolactinoma RCTs
PHASE4This study aims to investigate if endoscopic trans-sphenoidal prolactinoma ...
Location
Amsterdam University Medical Center, loc. AMC
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
PHASE2There are no available medical treatment options for patients with non-func...
Location
Endocrinology Section - Hospital Universitário Clementino Fraga Filho/Federal University of Rio de Janeiro
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss
PHASE2This research study investigates the use of a drug, cabergoline, given imme...
Location
Stanford University
Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
NATo study the effects of rapid escalation of Cabergoline in comparison to co...
Location
Postgraduate Institute of Medical Education and Research
The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events
N/ATo assess the association between cabergoline and other dopamine agonists (...
Location
Multiple Locations
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
PHASE4This randomized, active-controlled, parallel-arm, single-blind trial is to ...
Location
University Hospital Basel, Dept. of Endocrinology, Metabolism & Diabetes
Cardiac Valve Complications in Prolactinomas Treated With Cabergoline
N/ADopamine agonists are first-line agents for the treatment of prolactinomas ...
Location
Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples
Cabergoline Reduces OHSS
PHASE3The present study was designed to provide clinical confirmation of Cb2's va...
Location
Multiple Locations
Clinical Guidance for Proper Treatment of Unexplained Resistant Hyperprolactinemia.
PHASE1Many women despite being well-treated in proper dose, with proper drug and ...
Location
Woman's Health University Hospital